330 related articles for article (PubMed ID: 22826868)
1. Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems.
Foged C
Ther Deliv; 2011 Aug; 2(8):1057-77. PubMed ID: 22826868
[TBL] [Abstract][Full Text] [Related]
2. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.
Nordly P; Madsen HB; Nielsen HM; Foged C
Expert Opin Drug Deliv; 2009 Jul; 6(7):657-72. PubMed ID: 19538037
[TBL] [Abstract][Full Text] [Related]
3. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
Marasini N; Kaminskas LM
Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
[TBL] [Abstract][Full Text] [Related]
4. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
5. License to kill: Formulation requirements for optimal priming of CD8(+) CTL responses with particulate vaccine delivery systems.
Foged C; Hansen J; Agger EM
Eur J Pharm Sci; 2012 Mar; 45(4):482-91. PubMed ID: 21888971
[TBL] [Abstract][Full Text] [Related]
6. Oxidized Carbon Nanosphere-Based Subunit Vaccine Delivery System Elicited Robust Th1 and Cytotoxic T Cell Responses.
Sawutdeechaikul P; Cia F; Bancroft G; Wanichwecharungruang S; Sittplangkoon C; Palaga T
J Microbiol Biotechnol; 2019 Mar; 29(3):489-499. PubMed ID: 30691253
[TBL] [Abstract][Full Text] [Related]
7. Modern subunit vaccines: development, components, and research opportunities.
Moyle PM; Toth I
ChemMedChem; 2013 Mar; 8(3):360-76. PubMed ID: 23316023
[TBL] [Abstract][Full Text] [Related]
8. Vaccine technologies: From whole organisms to rationally designed protein assemblies.
Karch CP; Burkhard P
Biochem Pharmacol; 2016 Nov; 120():1-14. PubMed ID: 27157411
[TBL] [Abstract][Full Text] [Related]
9. Potential of Cationic Liposomes as Adjuvants/Delivery Systems for Tuberculosis Subunit Vaccines.
Khademi F; Taheri RA; Momtazi-Borojeni AA; Farnoosh G; Johnston TP; Sahebkar A
Rev Physiol Biochem Pharmacol; 2018; 175():47-69. PubMed ID: 29700609
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory properties of chitosan polymers.
Moran HBT; Turley JL; Andersson M; Lavelle EC
Biomaterials; 2018 Nov; 184():1-9. PubMed ID: 30195140
[TBL] [Abstract][Full Text] [Related]
11. Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators.
Tandrup Schmidt S; Foged C; Korsholm KS; Rades T; Christensen D
Pharmaceutics; 2016 Mar; 8(1):. PubMed ID: 26978390
[TBL] [Abstract][Full Text] [Related]
12. Bacterial ghosts as adjuvant particles.
Riedmann EM; Kyd JM; Cripps AW; Lubitz W
Expert Rev Vaccines; 2007 Apr; 6(2):241-53. PubMed ID: 17408373
[TBL] [Abstract][Full Text] [Related]
13. Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.
Moyle PM
Biotechnol Adv; 2017; 35(3):375-389. PubMed ID: 28288861
[TBL] [Abstract][Full Text] [Related]
14. Saponins from the Spanish saffron Crocus sativus are efficient adjuvants for protein-based vaccines.
Castro-Díaz N; Salaun B; Perret R; Sierro S; Romero JF; Fernández JA; Rubio-Moraga A; Romero P
Vaccine; 2012 Jan; 30(2):388-97. PubMed ID: 22079266
[TBL] [Abstract][Full Text] [Related]
15. PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.
Silva AL; Soema PC; Slütter B; Ossendorp F; Jiskoot W
Hum Vaccin Immunother; 2016 Apr; 12(4):1056-69. PubMed ID: 26752261
[TBL] [Abstract][Full Text] [Related]
16. Microparticles as vaccine adjuvants and delivery systems.
O'Hagan DT; Singh M
Expert Rev Vaccines; 2003 Apr; 2(2):269-83. PubMed ID: 12899577
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of vaccine potency through improved delivery.
Ulmer JB
Expert Opin Biol Ther; 2004 Jul; 4(7):1045-51. PubMed ID: 15268672
[TBL] [Abstract][Full Text] [Related]
18. Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.
Zhang R; Kramer JS; Smith JD; Allen BN; Leeper CN; Li X; Morton LD; Gallazzi F; Ulery BD
AAPS J; 2018 Jun; 20(4):73. PubMed ID: 29858738
[TBL] [Abstract][Full Text] [Related]
19. Particulate vaccines: on the quest for optimal delivery and immune response.
De Temmerman ML; Rejman J; Demeester J; Irvine DJ; Gander B; De Smedt SC
Drug Discov Today; 2011 Jul; 16(13-14):569-82. PubMed ID: 21570475
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in vaccine adjuvants.
Singh M; O'Hagan DT
Pharm Res; 2002 Jun; 19(6):715-28. PubMed ID: 12134940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
